Effects of two common polymorphisms of peroxisome proliferator-activated receptor-γ gene on metabolic syndrome

Archives of Medical Research

Volumn 37, Issue 1, 2006, Pages 86-94

  Rhee, Eun Jung ^a   Oh, Ki Won ^b   Lee, Won Young ^a   Kim, Se Yeon ^a   Oh, Eun Sook ^c   Baek, Ki Hyun ^d   Kang, Moo Il ^d   Kim, Sun Woo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Hallym University   (South Korea)

^c Mizmedi Hospital   (South Korea)

^d The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Atherosclerosis; Insulin resistance; Metabolic syndrome; PPAR polymorphism

Indexed keywords

ALANINE; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY FAT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DNA POLYMORPHISM; EXON; FEMALE; GENE FREQUENCY; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HOMEOSTASIS; HOMOZYGOSITY; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; KOREA; MATHEMATICAL COMPUTING; METABOLIC SYNDROME X; OBESITY; POLYMERASE CHAIN REACTION; PREVALENCE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; WAIST CIRCUMFERENCE; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AMINO ACID SUBSTITUTION; FEMALE; HUMANS; METABOLIC SYNDROME X; MIDDLE AGED; POINT MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PPAR GAMMA; PREDICTIVE VALUE OF TESTS;

EID: 28444478107     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2005.04.008     Document Type: Article

References (49)

1. B. Isomaa, P. Almgren, T. Tuomi, B. Forsen, K. Lahti, M. Nissen, M.R. Taskinen, and L. Groop Cardiovascular morbidity and mortality associated with the metabolic syndrome Diabetes Care 24 2001 683 689
2. P. Bjorntorp Abdominal obesity and the metabolic syndrome Ann Med 24 1992 465 468
3. L. Mykkanen, D.J. Zaccaro, L.E. Wagenknecht, D.C. Robbins, M. Gabriel, and S.M. Haffner Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study Diabetes 47 1998 793 800
4. J.H. Warram, B.C. Martin, A.S. Krolewski, J.S. Soeldner, and C.R. Kahn Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents Ann Intern Med 113 1990 909 915
5. L. Groop Genetics of the metabolic syndrome Br J Nutr 83 Suppl 1 2000 S39 S48
6. M. Lehtovirta, J. Kaprio, C. Forsblom, J. Eriksson, J. Tuomilehto, and L. Groop Insulin sensitivity and insulin secretion in monozygotic and dizygotic twins Diabetologia 43 2000 285 293
7. E.J. Mayer, B. Newman, M.A. Austin, D. Zhang, C.P. Quesenberry Jr., K. Edwards, and J.V. Selby Genetic and environmental influences on insulin levels and the insulin resistance syndrome: an analysis of women twins Am J Epidemiol 143 1996 323 332
8. Y. Hong, N.L. Pedersen, K. Brismar, and U. de Faire Genetic and environmental architecture of the features of the insulin-resistance syndrome Am J Hum Genet 60 1997 143 152
9. B. Desvergne, and W. Wahli Peroxisome proliferator-activated receptors: nuclear control of metabolism Endocr Rev 20 1999 649 688
10. E.D. Rosen, and B.M. Spiecelman PPARγ: a nuclear regulator of metabolism, differentiation, and cell growth J Biol Chem 276 2001 37731 37734
11. L. Fajas, D. Auboeuf, E. Raspe, K. Schoonjans, A.M. Lefebvre, R. Saladin, J. Najib, M. Laville, J.C. Fruchart, S. Deeb, A. Vidal-Puig, J. Flier, M.R. Briggs, B. Staels, H. Vidal, and J. Auwerx The organization, promoter analysis, and expression of the human PPARγ gene J Biol Chem 272 1997 18779 18789
12. L. Fajas, J.C. Fruchart, and J. Auwerx PPARγ 3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter FEBS Lett 438 1998 55 60
13. M. Ricote, J. Huang, L. Fajas, A. Li, J. Welch, J. Najib, J.L. Witztum, J. Auwerx, W. Palinski, and C.K. Glass Expression of the peroxisome proliferator-activated receptor gamma (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein Proc Natl Acad Sci USA 95 1998 7614 7619
14. P. Tontonoz, E. Hu, R.A. Graves, A.I. Budavari, and B.M. Spiegelman mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer Genes Dev 8 1994 1224 1234
15. H. Sundvold, and S. Lien Identification of a novel peroxisome proliferator-activated receptor PPARγ promoter in man and transactivation by the nuclear receptor RORα1 Biochem Biophys Res Commun 287 2001 383 390
16. F.P. Mancini, O. Vaccaro, L. Sabatino, A. Tufano, A.A. Rivellese, G. Riccardi, and V. Colantuoni Pro12Ala substitution in the peroxisome proliferator-activated receptor-γ2 is not associated with type 2 diabetes Diabetes 48 1999 1466 1468
17. J. Ringel, S. Engeli, A. Distler, and A.M. Sharma Pro12Ala missense mutation of the peroxisome proliferator activated receptor γ and diabetes mellitus Biochem Biophys Res Commun 254 1999 450 453
18. K. Clement, S. Hercberg, B. Passinge, P. Galan, M. Varroud-Vial, A.R. Shuldiner, B.A. Beamer, G. Charpentier, B. Guy-Grand, P. Froguel, and C. Vaisse The Pro115Gln and Pro12Ala PPARγ gene mutations in obesity and type 2 diabetes Int J Obes Relat Metab Disord 24 2000 391 393
19. K. Hara, T. Okada, K. Tobe, K. Yasuda, Y. Mori, H. Kadowaki, R. Hagura, Y. Akanuma, S. Kimura, C. Ito, and T. Kadowaki The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes Biochem Biophys Res Commun 271 2000 212 216
20. A. Meirhaeghe, L. Fajas, N. Helbecque, D. Cottel, J. Auwerx, S.S. Deeb, and P. Amouyel Impact of the peroxisome proliferator activated receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus Int J Obes Relat Metab Disord 24 2000 195 199
21. D. Altshuler, J.N. Hirschhorn, M. Klannemark, C.M. Lindgren, M.C. Vohl, J. Nemesh, C.R. Lane, S.F. Schaffner, S. Bolk, C. Brewer, T. Tuomi, D. Gaudet, T.J. Hudson, M. Daly, L. Groop, and E.S. Lander The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes Nat Genet 26 2000 76 80
22. A. Meirhaeghe, L. Fajas, N. Helbecque, D. Cottel, P. Lebel, J. Dallongeville, S. Deeb, J. Auwerx, and P. Amouyel A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans Hum Mol Genet 7 1998 435 440
23. S. Ogawa, T. Urano, T. Hosoi, M. Miyao, S. Hoshino, M. Fujita, M. Shiraki, H. Orimo, Y. Ouchi, and S. Inoue Association of bone mineral density with a polymorphism of the peroxisome proliferator-activated receptor gamma gene: PPARgamma expression in osteoblasts Biochem Biophys Res Commun 260 1999 122 126
24. R. Valve, K. Sivenius, R. Miettinen, J. Pihlajamaki, A. Rissanen, S.S. Deeb, J. Auwerx, M. Uusitupa, and M. Laakso Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women J Clin Endocrinol Metab 84 1999 3708 3712
25. P. Poulsen, G. Andersen, M. Fenger, T. Hansen, S.M. Echwald, A. Volund, H. Beck-Nielsen, O. Pedersen, and A. Vaag Impact of two common polymorphisms in the PPARgamma gene on glucose tolerance and plasma insulin profiles in monozygotic and dizygotic twins: thrifty genotype, thrifty phenotype, or both? Diabetes 52 2003 194 198
26. X.L. Wang, J. Oosterhof, and N. Duarte Peroxisome proliferator-activated receptor gamma C161→T polymorphism and coronary artery disease Cardiovasc Res 44 1999 588 594
27. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2496
28. WHO Western Pacific Region, IASO and IOTF: The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Sydney, Australia, Health Communications Australia Pty Limit, 2000
29. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostatic model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man Diabetologia 28 1985 412 419
30. A. Katz, S.S. Nambi, K. Mather, A.D. Baron, D.A. Follmann, G. Sullivan, and M.J. Quon Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans J Clin Endocrinol Metab 85 2000 2402 2410
31. E.Y. Oh, K.M. Min, J.H. Chung, Y.K. Min, M.S. Lee, K.W. Kim, and M.K. Lee Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects J Clin Endocrinol Metab 85 2000 1801 1814
32. Y. Yamamoto, H. Hirose, K. Miyashita, K. Nishikai, I. Saito, M. Taniyama, M. Tomita, and T. Saruta PPAR(gamma)2 gene Pro12Ala polymorphism may influence serum level of an adipocyte-derived protein, adiponectin, in the Japanese population Metabolism 51 2002 1407 1409
33. M. Nemoto, T. Sasaki, S.S. Deeb, W.Y. Fujimoto, and N. Tajima Differential effect of PPARgamma2 variants in the development of type 2 diabetes between native Japanese and Japanese Americans Diabetes Res Clin Pract 57 2002 131 137
34. J.L. Gonzalez Sanchez, M. Serrano Rios, C. Fernandez Perez, M. Laakso, and M.T. Martinez Larrad Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population Eur J Endocrinol 147 2002 495 501
35. S. Masud, S. Ye, and SAS Group Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: a meta-analysis J Med Genet 40 2003 773 780
36. M. Gurnell PPARgamma and metabolism: insights from the study of human genetic variants Clin Endocrinol 59 2003 267 277
37. P. Puddu, G.M. Puddu, and A. Muscari Peroxisome proliferator-activated receptors: are they involved in atherosclerosis progression? Int J Cardiol 90 2003 133 140
38. W.A. Hsueh, and R. Law The central role of fat and effect of peroxisome proliferator-activated receptor-gamma on progression of insulin resistance and cardiovascular disease Am J Cardiol 92 2003 3J 9J
39. C.J. Yen, B.A. Beamer, C. Negri, K. Silver, K.A. Brown, D.P. Yarnall, D.K. Burns, J. Roth, and A.R. Shuldiner Molecular scanning of the human peroxisome proliferator activated receptor gamma(hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation Biochem Biophys Res Commun 241 1997 270 274
40. S.S. Deeb, L. Fajas, M. Nemoto, J. Pihlajamaki, L. Mykkanen, J. Kuusisto, M. Laakso, W. Fujimoto, and J. Auwerx A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity Nat Genet 20 1998 284 287
41. L. Frederiksen, K. Brodbaek, M. Fenger, T. Jorgensen, K. Borch-Johnsen, S. Madsbad, and S.A. Urhammer Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome J Clin Endocrinol Metab 87 2002 3989 3992
42. V. Fuster, A.M. Gotto, P. Libby, J. Loscalzo, and H.C. McGill 27th Bethesda Conference: Matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 1. Pathogenesis of coronary disease: the biologic role of risk factors J Am Coll Cardiol 27 1996 964 976
43. H.B. Brewer Jr. Increasing HDL cholesterol levels N Engl J Med 350 2004 1491 1494
44. D. Reichl, and N.E. Miller Pathophysiology of reverse cholesterol transport: insights from inherited disorders of lipoprotein metabolism Arteriosclerosis 9 1989 785 797
45. D.Q. Peng, S.P. Zhao, S. Nie, and J. Li Gene-gene interaction of PPARgamma and ApoE affects coronary heart disease risk Int J Cardiol 92 2003 257 263
46. R.A. DeFronzo, J.D. Tobin, and R. Andres Glucose clamp technique: a method for quantifying insulin secretion and resistance Am J Physiol 237 1979 E214 E223
47. T.M. Wallace, and D.R. Matthews The assessment of insulin resistance in man Diabet Med 19 2002 527 534
48. K.J. Mather, A.E. Hunt, H.O. Steinberg, G. Paradisi, G. Hook, A. Katz, M.J. Quon, and A.D. Baron Repeatability characteristics of simple indices of insulin resistance: implications for research applications J Clin Endocrinol Metab 86 2001 5457 5464
49. J. Hrebicek, V. Janout, J. Malincikova, D. Horakova, and L. Cizek Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention J Clin Endocrinol Metab 87 2002 144 147